Hetal Kocinsky - Apr 28, 2025 Form 3 Insider Report for Jade Biosciences, Inc. (JBIO)

Role
Chief Medical Officer
Signature
/s/ Elizabeth Balta, as attorney-in-fact for Hetal Kocinsky
Stock symbol
JBIO
Transactions as of
Apr 28, 2025
Transactions value $
$0
Form type
3
Date filed
5/1/2025, 05:30 PM
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding JBIO Stock Option (Right to Buy) Apr 28, 2025 Common Stock 186K $1.53 Direct F1
holding JBIO Stock Option (Right to Buy) Apr 28, 2025 Common Stock 354K $6.03 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option represents a right to purchase 186,225 shares of the Issuer's common stock, one quarter of which will vest on September 9, 2025, with the remaining three quarters vesting in equal monthly installments over the following three years, subject to the Reporting Person's continued service to the Issuer on each such vesting date.
F2 This option represents a right to purchase 353,533 shares of the Issuer's common stock, one quarter of which will vest on January 29, 2026, with the remaining three quarters vesting in equal monthly installments over the following three years, subject to the Reporting Person's continued service to the Issuer on each such vesting date.

Remarks:

Exhibit 24 - Power of Attorney